PH23819A - Morpholinoethylester of mycophenolic acid and derivatives thereof - Google Patents

Morpholinoethylester of mycophenolic acid and derivatives thereof

Info

Publication number: PH23819A
Authority: PH; Philippines
Prior art keywords: agents; morpholinoethylester; derivatives; mycophenolic acid; chem
Prior art date: 1987-01-30

Application number

PH36232A

Other languages

English (en)

Inventor

Peter H Nelson

Chee-Liang Leo Gu

Anthony C Allison

Elsie M Eugui

William A Lee

Original Assignee

Syntex Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-01-30

Filing date

1987-12-15

Publication date

1989-11-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21733252&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH23819(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-12-15 Application filed by Syntex Inc filed Critical Syntex Inc

1989-11-23 Publication of PH23819A publication Critical patent/PH23819A/en

Links

HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 title 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 title 1
229960000951 mycophenolic acid Drugs 0.000 title 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
239000002260 anti-inflammatory agent Substances 0.000 abstract 1
229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
230000002682 anti-psoriatic effect Effects 0.000 abstract 1
239000002246 antineoplastic agent Substances 0.000 abstract 1
239000003443 antiviral agent Substances 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
229940125721 immunosuppressive agent Drugs 0.000 abstract 1
239000003018 immunosuppressive agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Furan Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Saccharide Compounds (AREA)

PH36232A 1987-01-30 1987-12-15 Morpholinoethylester of mycophenolic acid and derivatives thereof PH23819A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/008,717 US4753935A (en)	1987-01-30	1987-01-30	Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
PH23819A true PH23819A (en)	1989-11-23

Family

ID=21733252

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH36232A PH23819A (en)	1987-01-30	1987-12-15	Morpholinoethylester of mycophenolic acid and derivatives thereof

Country Status (26)

Country	Link
US (7)	US4753935A (de)
EP (1)	EP0281713B1 (de)
JP (1)	JPS63188672A (de)
KR (1)	KR940003758B1 (de)
AT (1)	ATE68180T1 (de)
AU (1)	AU599728B2 (de)
CA (1)	CA1333285C (de)
DE (2)	DE19675020I2 (de)
DK (1)	DK166675B1 (de)
ES (1)	ES2038190T3 (de)
FI (1)	FI85141C (de)
GE (1)	GEP20094816B (de)
GR (1)	GR3002866T3 (de)
HK (1)	HK125893A (de)
HU (2)	HU201927B (de)
IE (1)	IE60750B1 (de)
IL (1)	IL84833A (de)
LU (1)	LU88795I2 (de)
LV (1)	LV5748B4 (de)
MX (1)	MX9203163A (de)
NL (1)	NL960019I2 (de)
NO (2)	NO171680C (de)
NZ (1)	NZ222922A (de)
PH (1)	PH23819A (de)
PT (1)	PT86343B (de)
ZA (1)	ZA879414B (de)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5177072A (en) *	1987-01-30	1993-01-05	Syntex (U.S.A.) Inc.	Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
AU632796B2 (en) *	1989-02-23	1993-01-14	University Of North Carolina At Chapel Hill, The	Etoposide analogues
US5219851A (en) *	1991-03-05	1993-06-15	Warner-Lambert Company	Tetrahydroisoquinoline-type renin inhibiting peptides
US5247083A (en) *	1992-07-10	1993-09-21	Syntex (U.S.A.) Inc.	Direct esterification of mycophenolic acid
WO1994012184A1 (en) *	1992-11-24	1994-06-09	Syntex (U.S.A.) Inc.	Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5455045A (en) *	1993-05-13	1995-10-03	Syntex (U.S.A.) Inc.	High dose formulations
PL176595B1 (pl) *	1993-06-25	1999-06-30	Main Camp Marketing Pty Ltd	Środek leczniczy w postaci koncentratu z nasion selera i sposób otrzymywania środka leczniczego w postaci koncentratu z nasion selera
JP3411038B2 (ja) *	1993-09-15	2003-05-26	シンテックス（ユー・エス・エイ）・インコーポレイテッド	ミコフェノール酸モフェチルの結晶質無水物およびその静注用製剤
EP1475091A1 (de) *	1993-10-01	2004-11-10	Roche Palo Alto LLC	Hochdosierte oral anzuwendende Suspensionen enthaltend Mycophenolat Mofetil
US5493030A (en) *	1994-02-18	1996-02-20	Syntex (U.S.A.) Inc.	5-substituted derivatives of mycophenolic acid
US5444072A (en) *	1994-02-18	1995-08-22	Syntex (U.S.A.) Inc.	6-substituted mycophenolic acid and derivatives
US5380879A (en) *	1994-02-18	1995-01-10	Syntex (U.S.A.) Inc.	Derivatives of mycophenolic acid
US5512568A (en) *	1994-02-18	1996-04-30	Syntex (U.S.A.) Inc.	Method of using 4-amino derivatives of 5-substituted mycophenolic acid
US5525602A (en) *	1994-02-18	1996-06-11	Syntex (U.S.A.) Inc.	Method of using 4-amino 6-substituted mycophenolic acid and derivatives
US6225073B1 (en)	1994-07-07	2001-05-01	Dade Behring Marburg Gmbh	Immunoassay for mycophenolic acid
ID18663A (id) *	1996-04-12	1998-04-30	Novartis Ag	Komposisi farmasi berlapis enterik
WO2000025780A1 (en)	1998-10-29	2000-05-11	Bristol-Myers Squibb Company	Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
US6420403B1 (en)	1998-10-29	2002-07-16	Edwin J. Iwanowicz	Inhibitors of IMPDH enzyme
US6596747B2 (en)	1998-10-29	2003-07-22	Bristol-Myers Squibb Company	Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
CA2348267A1 (en) *	1998-10-29	2000-05-11	Henry H. Gu	Novel inhibitors of impdh enzyme
IN188985B (de)	1998-12-09	2002-11-30	Biocon Ltd
US6514979B1 (en)	1999-03-03	2003-02-04	University Of Maryland Biotechnology Institute	Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
US6107052A (en) *	1999-06-09	2000-08-22	Roche Diagnostics Corporation	Enzymatic measurement of mycophenolic acid
AU5553801A (en) *	2000-04-24	2001-11-07	Bristol Myers Squibb Co	Heterocycles that are inhibitors of impdh enzyme
US6471980B2 (en)	2000-12-22	2002-10-29	Avantec Vascular Corporation	Intravascular delivery of mycophenolic acid
US7179791B2 (en) *	2001-01-11	2007-02-20	Duke University	Inhibiting GS-FDH to modulate NO bioactivity
GB0124953D0 (en) *	2001-10-17	2001-12-05	Novartis Ag	Organic Compounds
TW200301698A (en) *	2001-12-21	2003-07-16	Bristol Myers Squibb Co	Acridone inhibitors of IMPDH enzyme
EP2316468A1 (de)	2002-02-22	2011-05-04	Shire LLC	Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Dextroamphetamin
AU2003261354A1 (en) *	2002-08-02	2004-02-23	The Regents Of The University Of California	New uses for inhibitors of inosine monophosphate dehydrogenase
TWI221414B (en) *	2003-02-21	2004-10-01	Chunghwa Chemical Synthesis &	Method of making mycophenolate mofetil using transesterification
GB0307553D0 (en) *	2003-04-01	2003-05-07	Novartis Ag	Organic compounds
AU2003231924A1 (en) *	2003-04-07	2004-11-01	Biocon Limited	Microwave synthesis of mycophenolate
WO2004100945A1 (en) *	2003-05-14	2004-11-25	Dsm Ip Assets B.V.	Use of phthalide derivatives for the treatment and prevention of diabetes mellitus
US20050187170A1 (en) *	2003-06-16	2005-08-25	Biocryst Pharmaceuticals, Inc.	Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors
DE602004015310D1 (de) *	2003-09-11	2008-09-04	Sandoz Ag	Verfahren zur herstellung von mycophenolatmofetil
CN100518733C (zh) *	2003-09-23	2009-07-29	帝斯曼知识产权资产管理有限公司	用于治疗和预防糖尿病的组合物
AU2003272083A1 (en) *	2003-10-07	2005-04-21	Biocon Limited	Salt of 6-(1, 3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid with n, n-dimethyl-imidodicarbonimidic diamide
MXPA06005659A (es) *	2004-04-26	2007-04-10	Teva Gyogyszergyar Zartkoruen	Proceso para preparacion de acido micofenolico y derivados de ester del mismo.
EP1740563A2 (de) *	2004-04-27	2007-01-10	Teva Gyógyszergyár Zártköruen Muködo Részvenytarsaság	Mykophenolatmofetilverunreinigung
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
US7439373B2 (en) *	2004-07-20	2008-10-21	TEVA Gyógyszergyár Zártkörúen Múködö Részvénytársaság	Crystalline mycophenolate sodium
CA2577169A1 (en) *	2004-08-16	2006-02-23	The University Of Queensland	Metabolism-modulating agents and uses therefor
WO2006076802A1 (en) *	2005-01-20	2006-07-27	Apotex Fermentation Inc.	An improved process for the preparation of mycophenolate mofetil
EP1917010A2 (de) *	2005-02-08	2008-05-07	Aspreva Pharmaceuticals SA	Zusammensetzungen und verfahren zur behandlung von gefäss-, autoimmun- und entzündlichen erkrankungen
US20060235009A1 (en) *	2005-02-08	2006-10-19	Richard Glickman	Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
US20080281111A1 (en) *	2005-04-26	2008-11-13	Sandor Molnar	Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
CN100402516C (zh) *	2005-10-18	2008-07-16	深圳市东阳光实业发展有限公司	一种霉酚酸莫啡酯的制备方法
US20090023805A1 (en) *	2006-02-13	2009-01-22	Anne Claire Marrast	Method of administration
WO2008003637A2 (en) *	2006-07-05	2008-01-10	Dsm Ip Assets B.V.	Isolation and use of amine salts of mycophenolic acid
WO2008033466A2 (en) *	2006-09-14	2008-03-20	Combinatorx (Singapore) Pre. Ltd.	Compositions and methods for treatment of viral diseases
US20080188653A1 (en) *	2007-02-04	2008-08-07	Formosa Laboratories, Inc.	Process for Preparation of Mycophenolate Mofetil
CN100484930C (zh) *	2007-03-16	2009-05-06	重庆大新药业股份有限公司	一种吗替麦考酚酯的制备方法
WO2009000834A1 (en) *	2007-06-27	2008-12-31	Dsm Ip Assets B.V.	Method for the purification of mycophenolate mofetil
WO2009010503A1 (en) *	2007-07-18	2009-01-22	Dsm Ip Assets B.V.	Mycophenolic acid recycling in a method for the preparation of mycophenolate mofetil
US20090076000A1 (en) *	2007-09-15	2009-03-19	Protia, Llc	Deuterium-enriched mycophenolate mofetil
TW200932240A (en)	2007-10-25	2009-08-01	Astellas Pharma Inc	Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
WO2009084008A1 (en) *	2007-12-28	2009-07-09	Cadila Healthcare Limited	Process for preparing mycophenolate mofetil
KR100975520B1 (ko) *	2008-02-01	2010-08-12	종근당바이오 주식회사	마이코페놀레이트 모페틸의 개선된 제조방법
US8173621B2 (en)	2008-06-11	2012-05-08	Gilead Pharmasset Llc	Nucleoside cyclicphosphates
EP2310008A4 (de) *	2008-07-09	2014-03-05	Aspreva Internat Ltd	Ph-spezifische lösungen aus natriummycophenolsäure zur behandlung von augenleiden
AU2009329872B2 (en)	2008-12-23	2016-07-07	Gilead Pharmasset Llc	Synthesis of purine nucleosides
NZ593649A (en) *	2008-12-23	2013-11-29	Gilead Pharmasset Llc	Nucleoside analogs
PA8855601A1 (es)	2008-12-23	2010-07-27		Forformidatos de nucleósidos
FI124873B (fi)	2009-10-06	2015-02-27	Maricap Oy	Menetelmä ja laitteisto pneumaattisessa materiaalinsiirtojärjestelmässä
FI20096026A7 (fi)	2009-10-06	2011-04-07	Maricap Oy	Menetelmä ja laitteisto pneumaattisessa materiaalinsiirtojärjestelmässä
SG184324A1 (en)	2010-03-31	2012-11-29	Gilead Pharmasset Llc	Nucleoside phosphoramidates
GB201100786D0 (en)	2011-01-18	2011-03-02	Ems Sa	Pharmaceutical compositions of immunosuppressants
CN102952105A (zh) *	2011-08-26	2013-03-06	中国科学院上海药物研究所	一类霉酚酸衍生物、其制备方法和用途
WO2013041205A1 (de)	2011-09-19	2013-03-28	Pyxirion Pharma Gmbh	Neue therapeutische konzepte zur behandlung von gefässerkrankungen
KR102085557B1 (ko)	2013-03-14	2020-03-06	엘커메스 파마 아일랜드 리미티드	푸마레이트의 프로드럭 및 다양한 질환을 치료하는데 있어서의 이들의 용도
US8669281B1 (en)	2013-03-14	2014-03-11	Alkermes Pharma Ireland Limited	Prodrugs of fumarates and their use in treating various diseases
US10369133B2 (en)	2013-07-23	2019-08-06	The University Of Tennessee Research Foundation	Immunosuppressive compounds and therapeutics
WO2015105174A1 (ja) *	2014-01-10	2015-07-16	富士フイルム株式会社	５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミドの有効投与量または感受性の予測方法および予測装置、キサントシン一リン酸の量の測定方法ならびに骨髄異形成症候群の処置剤および処置方法
JP6337135B2 (ja)	2014-02-24	2018-06-06	アルカーメスファーマアイルランドリミテッド	フマル酸エステルのスルホンアミドプロドラッグ及びスルフィンアミドプロドラッグ並びに種々の疾患の治療におけるその使用
US12011429B2 (en)	2016-06-02	2024-06-18	Steven Baranowitz	Prevention and treatment of viral infections
CA3026241A1 (en)	2016-06-02	2017-12-07	Steven Baranowitz	Prevention and treatment of viral infections
US10603299B2 (en)	2016-06-02	2020-03-31	Steven Baranowitz	Prevention and treatment of viral infections
WO2018167628A1 (en)	2017-03-13	2018-09-20	Ftf Pharma Private Limited	Pharmaceutical composition of oral suspension of immunosuppressive agents
US10835489B2 (en) *	2018-03-09	2020-11-17	University Of Saskatchewan	Modified release formulations of mycophenolate mofetil
WO2020039263A2 (en)	2018-08-18	2020-02-27	Ftf Pharma Private Limited	Pharmaceutical suspension for oral dosage
CN110526885A (zh) *	2019-08-20	2019-12-03	上海英诺富成生物科技有限公司	麦考酚酸的前体药物及其制备方法
CN113549040B (zh) *	2020-04-23	2024-08-06	鲁南制药集团股份有限公司	一种吗替麦考酚酯杂质d的制备方法
CN112121173B (zh) *	2020-08-22	2022-05-06	浙江大学	脂肪酸修饰的免疫抑制剂mmf及fk506纳米制剂及其制备方法和应用
WO2022187379A1 (en)	2021-03-03	2022-09-09	Sana Biotechnology, Inc.	Immunosuppressive therapies for use with cardiomyocyte cell therapies, and associated methods and compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1157100A (en) *	1966-09-27	1969-07-02	Ici Ltd	Pharmaceutical Compositions
GB1173942A (en) *	1967-06-06	1969-12-10	Bellon Labor Sa Roger	New 2,3-Dihydro-1,4-Benzoxazines
GB1261060A (en) *	1969-09-09	1972-01-19	Ici Ltd	Phthalen-1-one derivatives
US3825571A (en) *	1971-07-31	1974-07-23	Chugai Pharmaceutical Co Ltd	Mycophenolic acid derivatives
JPS5542995B2 (de) *	1972-02-24	1980-11-04
JPS5529994B2 (de) *	1972-03-02	1980-08-07
JPS563353B2 (de) *	1972-03-02	1981-01-24
US3868454A (en) *	1972-08-14	1975-02-25	Lilly Co Eli	Psoriasis treatment with mycophenolic acid derivatives
US3777020A (en) *	1972-08-14	1973-12-04	Lilly Co Eli	Psoriasis treatment with mycophenolic acid
US3880995A (en) *	1973-05-14	1975-04-29	Lilly Co Eli	Treatment of arthritis with mycophenolic acid and derivatives
US3903071A (en) *	1973-05-22	1975-09-02	Lilly Co Eli	Mycophenolic acid derivatives
US3905894A (en) *	1973-10-02	1975-09-16	Murskauskone Oy	Apparatus for wet fine screening
JPS5724380A (en) *	1980-07-22	1982-02-08	Chugai Pharmaceut Co Ltd	Preparation of mycophenolic acid derivative
JPS57183776A (en) *	1981-05-01	1982-11-12	Ajinomoto Co Inc	Preparation of mycophenolic acid derivative
JPS57183777A (en) *	1981-05-01	1982-11-12	Ajinomoto Co Inc	Preparation of mycophenolic acid derivative
IT1150194B (it) *	1982-02-23	1986-12-10	Chiesi Farma Spa	Formulazioni farmaceutiche ad attivita'antiinfiammatoria, analgesica,antipiretica e gastroprotettiva

1987
- 1987-01-30 US US07/008,717 patent/US4753935A/en not_active Expired - Lifetime
- 1987-09-04 US US07/093,459 patent/US4808592A/en not_active Expired - Lifetime
- 1987-12-11 PT PT86343A patent/PT86343B/pt active IP Right Revival
- 1987-12-15 ES ES198787311021T patent/ES2038190T3/es not_active Expired - Lifetime
- 1987-12-15 AU AU82540/87A patent/AU599728B2/en not_active Expired
- 1987-12-15 IL IL84833A patent/IL84833A/xx not_active IP Right Cessation
- 1987-12-15 DE DE1996175020 patent/DE19675020I2/de active Active
- 1987-12-15 PH PH36232A patent/PH23819A/en unknown
- 1987-12-15 ZA ZA879414A patent/ZA879414B/xx unknown
- 1987-12-15 DE DE8787311021T patent/DE3773660D1/de not_active Expired - Lifetime
- 1987-12-15 AT AT87311021T patent/ATE68180T1/de active
- 1987-12-15 LU LU88795C patent/LU88795I2/fr unknown
- 1987-12-15 FI FI875502A patent/FI85141C/fi not_active IP Right Cessation
- 1987-12-15 CA CA000554352A patent/CA1333285C/en not_active Expired - Lifetime
- 1987-12-15 HU HU875663A patent/HU201927B/hu unknown
- 1987-12-15 EP EP87311021A patent/EP0281713B1/de not_active Expired - Lifetime
- 1987-12-15 NO NO875240A patent/NO171680C/no not_active IP Right Cessation
- 1987-12-15 NZ NZ222922A patent/NZ222922A/xx unknown
- 1987-12-15 KR KR1019870014353A patent/KR940003758B1/ko not_active Expired - Lifetime
- 1987-12-15 JP JP62320066A patent/JPS63188672A/ja active Granted
- 1987-12-15 DK DK658787A patent/DK166675B1/da not_active IP Right Cessation
- 1987-12-15 IE IE339787A patent/IE60750B1/en not_active IP Right Cessation
1988
- 1988-01-22 US US07/146,883 patent/US4786637A/en not_active Expired - Lifetime
- 1988-08-17 US US07/233,200 patent/US4868153A/en not_active Expired - Lifetime
- 1988-11-14 US US07/272,161 patent/US4952579A/en not_active Expired - Lifetime
1989
- 1989-06-29 US US07/373,413 patent/US4948793A/en not_active Expired - Lifetime
1990
- 1990-03-28 US US07/500,439 patent/US4992467A/en not_active Expired - Lifetime
1991
- 1991-10-10 GR GR91400377T patent/GR3002866T3/el unknown
1992
- 1992-06-23 MX MX9203163A patent/MX9203163A/es unknown
1993
- 1993-11-11 HK HK1258/93A patent/HK125893A/en not_active IP Right Cessation
1994
- 1994-07-01 HU HU94P/P00008P patent/HU210350A9/hu unknown
1996
- 1996-07-05 LV LV960221A patent/LV5748B4/xx unknown
- 1996-07-12 NL NL960019C patent/NL960019I2/nl unknown
1997
- 1997-07-01 NO NO1997007C patent/NO1997007I1/no unknown
2006
- 2006-07-17 GE GEAP19879526A patent/GEP20094816B/en unknown

Also Published As

Publication number	Publication date
NO171680B (no)	1993-01-11
ES2038190T3 (es)	1993-07-16
NZ222922A (en)	1990-09-26
ATE68180T1 (de)	1991-10-15
IE60750B1 (en)	1994-08-10
HU210350A9 (en)	1995-03-28
FI875502A0 (fi)	1987-12-15
LV5748B4 (lv)	1997-02-20
US4753935A (en)	1988-06-28
KR880009016A (ko)	1988-09-13
DE3773660D1 (de)	1991-11-14
EP0281713A1 (de)	1988-09-14
NO1997007I1 (no)	1997-07-01
DK166675B1 (da)	1993-06-28
PT86343B (pt)	1991-02-08
US4786637A (en)	1988-11-22
NO875240L (no)	1988-08-01
US4808592A (en)	1989-02-28
NL960019I1 (nl)	1996-10-01
NO875240D0 (no)	1987-12-15
NL960019I2 (nl)	1997-06-02
IE873397L (en)	1988-07-30
AU599728B2 (en)	1990-07-26
HUT47567A (en)	1989-03-28
CA1333285C (en)	1994-11-29
KR940003758B1 (ko)	1994-04-30
AU8254087A (en)	1988-08-04
EP0281713B1 (de)	1991-10-09
US4952579A (en)	1990-08-28
IL84833A0 (en)	1988-06-30
GR3002866T3 (en)	1993-01-25
ZA879414B (en)	1989-08-30
LU88795I2 (fr)	1996-11-05
DE19675020I2 (de)	2002-11-07
HU201927B (en)	1991-01-28
US4868153A (en)	1989-09-19
DK658787A (da)	1988-07-31
GEP20094816B (en)	2009-11-10
IL84833A (en)	1992-03-29
LV5748A4 (lv)	1996-10-20
FI875502L (fi)	1988-07-31
PT86343A (en)	1988-01-01
JPS63188672A (ja)	1988-08-04
FI85141B (fi)	1991-11-29
FI85141C (fi)	1992-03-10
US4948793A (en)	1990-08-14
MX9203163A (es)	1992-07-31
NO171680C (no)	1993-04-21
HK125893A (en)	1993-11-19
US4992467A (en)	1991-02-12
JPH0571591B2 (de)	1993-10-07
DK658787D0 (da)	1987-12-15

Publication	Publication Date	Title
NZ222922A (en)	1990-09-26	Morpholinoethylester of mycophenolic acid and derivatives and pharmaceutical compositions
MY103801A (en)	1993-09-30	Dideoxydidehydrocarbocyclic nucleosides
FI881816A0 (fi)	1988-04-19	Nya bicykliska foereningar, foerfarane foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI893130A0 (fi)	1989-06-27	Menetelmä uusien terapeuttisesti käyttökelpoisten estramustiiniestereiden valmistamiseksi
EP0408044A3 (en)	1991-07-17	Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
DE3477380D1 (en)	1989-04-27	Novel benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
EP0255164A3 (en)	1990-10-17	Use of a thioester for preparing pharmaceutical compositions for the treatment of ischemia and reperfusion syndromes
DK424888D0 (da)	1988-07-29	Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
LU88449I2 (fr)	1994-09-09	Fleroxacine et ses dérivés pharmaceutiquement acceptables.